Showing 676 news articles about New & experimental HIV treatments

Filters Content type: Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

Pharmaceutical industry

Rival drugmakers' joint trial of medicines for COVID includes an experimental HIV drug

Editor's pick
Thomson Reuters Foundation
4 August 2020
New & experimental HIV treatments

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Editor's pick
TheBodyPro
28 July 2020
New & experimental HIV treatments

FDA spurns CytoDyn's HIV drug because of missing info

Editor's pick
FierceBiotech
14 July 2020
New & experimental HIV treatments

Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

Editor's pick
Dewpoint press release
13 July 2020
Resistance

Doravirine Benefits HIV-1 Patients with Common Resistance Associated Mutations

Editor's pick
Contagion Live
8 July 2020
Injectable & long-acting HIV treatment

GSK says it is within weeks of resubmitting HIV injection Cabenuva

Editor's pick
Reuters
3 July 2020
New & experimental HIV treatments

ViiV Healthcare announces US FDA approval for Rukobia (fostemsavir), a first-in-class treatment for HIV in adults with few treatment options available

Editor's pick
ViiV press release
3 July 2020
New & experimental HIV treatments

Experimental HIV drug seems effective at a twice-a-year dose, study finds

Editor's pick
STAT
2 July 2020
New & experimental HIV treatments

Existing drugs may limit damage caused by HIV

Editor's pick
EurekAlert
24 June 2020
Coronavirus

New trial will give 75 coronavirus patients experimental HIV and cancer drug this month after two critically ill people in New York treated with the medication recovered

Editor's pick
Daily Mail
6 May 2020
Injectable & long-acting HIV treatment

Health Canada okays GSK unit's monthly HIV injection

Editor's pick
Reuters
23 March 2020
The search for a cure

Safety and PK of bNAb elipovimab (GS-9722) support two-weekly dosing

Editor's pick
i-Base
10 March 2020
New & experimental HIV treatments

Rockefeller grants commercial license for the development of broadly neutralizing antibodies

Editor's pick
Rockefeller University
27 February 2020
Injectable & long-acting HIV treatment

Unitaid invests in long-acting medicines to simplify treatment and prevention for HIV, TB, malaria and HCV

Editor's pick
Unitaid
7 February 2020
New & experimental HIV treatments

ViiV Healthcare submits regulatory application to the European Medicines Agency for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
ViiV Healthcare press release
13 January 2020
Injectable & long-acting HIV treatment

No holiday gift for GSK: FDA sends long-acting HIV injectable back to work

Editor's pick
FiercePharma
24 December 2019
Injectable & long-acting HIV treatment

FDA Defers Approval of First Long-Acting HIV Therapy, Surprising Everyone

Editor's pick
HIV and ID Observations
23 December 2019
New & experimental HIV treatments

CytoDyn Signs Definitive Agreements with Vyera Pharmaceuticals to Commercialize Leronlimab in the U.S. for the Treatment of HIV

Editor's pick
CytoDyn press release
18 December 2019
New & experimental HIV treatments

Capsid inhibitor GS-6207: potential for 6 monthly dosing for MDR HIV

Editor's pick
i-Base
16 December 2019
New & experimental HIV treatments

ViiV Healthcare submits New Drug Application to the FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults with few treatment options available

Editor's pick
5 December 2019
Government, leadership & policy

The World Cannot End HIV Without Continued Innovation

Editor's pick
POZ
25 November 2019
New & experimental HIV treatments

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational "bNAb" with potential for long-acting HIV treatment and prevention

Editor's pick
ViiV Healthcare press release
21 November 2019
PrEP science

Evaluating Microarray Patches for Long-Acting PrEP and Contraceptives

Editor's pick
Contagion Live
3 October 2019
New & experimental HIV treatments

European Commission Approves Trogarzo

Editor's pick
Global Newswire
27 September 2019